Status:
COMPLETED
Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Lead Sponsor:
ViiV Healthcare
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Infection, Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is a cross sectional observational study to evaluate the prevalence of HLA-B\*5701 in the major French ethnotypes. Any HIV-1 infected subject will be eligible for this study including anti...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- HIV-1 infected patients, ART naive or experienced over the age of 18 years.
- Patients must be either affiliated to or beneficiary of a social security category.
- Patient is willing and able to understand and provide written informed consent prior to participation in this study.
- Exclusion criteria:
- none
Exclusion
Key Trial Info
Start Date :
March 15 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
974 Patients enrolled
Trial Details
Trial ID
NCT00441688
Start Date
March 15 2007
End Date
June 1 2007
Last Update
August 22 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.